Article
Defining metabolic heterogeneity in polyendocrine metabolic ovarian syndrome based on the MTHFR C677T polymorphism: the potential pathway role of homocysteine.
Journal of ovarian research - 9 Sept 2026
Zhao Lidong, Li Peipei, Li Jinhua, Liu Hu, Wang Jinjuan, Qing Limei, Yang Jing, Wang Xiuzhen, Ha Lingxia
Abstract excerpt
BACKGROUND: Polyendocrine Metabolic Ovarian Syndrome (PMOS) is characterized by diverse endocrine and metabolic abnormalities. Patients differ substantially in obesity, insulin resistance, and cardiometabolic risk. Homocysteine (HCY) is associated with insulin resistance and metabolic abnormalities in patients with PMOS, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is an important...
Read the complete abstract on PubMedTopics
- Humans
- Female
- Methylenetetrahydrofolate Reductase (NADPH2)
- Homocysteine
- Metabolic Syndrome
- Genotype
